TG Therapeutics Inc (TGTX)
Quick ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 179,894 | 195,822 | 82,910 | 75,477 | 92,933 | 150,902 | 97,009 | 61,469 | 102,304 | 109,860 | 147,073 | 185,676 | 298,887 | 326,512 | 401,707 | 471,514 | 553,439 | 254,154 | 260,512 | 52,051 |
| Short-term investments | US$ in thousands | 131,106 | 145,219 | 134,342 | 134,308 | 124,575 | 78,257 | 47,896 | 78,241 | 59,374 | 66,082 | 48,636 | 47,525 | 15,876 | 30,338 | 41,752 | 52,334 | 51,987 | 46 | 15,058 | 26,284 |
| Receivables | US$ in thousands | 129,185 | 115,727 | 83,608 | 64,982 | 51,093 | 39,320 | 17,484 | 8,623 | 0 | — | 88 | 903 | 1,389 | 1,384 | 931 | 771 | — | — | — | — |
| Total current liabilities | US$ in thousands | 90,679 | 125,114 | 108,664 | 99,684 | 53,720 | 57,678 | 72,667 | 63,076 | 53,201 | 36,447 | 43,326 | 54,656 | 65,384 | 87,655 | 87,551 | 92,494 | 87,554 | 77,670 | 67,537 | 63,118 |
| Quick ratio | 4.85 | 3.65 | 2.77 | 2.76 | 5.00 | 4.65 | 2.23 | 2.35 | 3.04 | 4.83 | 4.52 | 4.28 | 4.84 | 4.09 | 5.08 | 5.67 | 6.91 | 3.27 | 4.08 | 1.24 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($179,894K
+ $131,106K
+ $129,185K)
÷ $90,679K
= 4.85
The quick ratio of TG Therapeutics Inc has shown some fluctuations over the years, ranging from a low of 1.24 on March 31, 2020, to a high of 6.91 on December 31, 2020. Generally, a quick ratio greater than 1 indicates that the company has enough liquid assets to cover its current liabilities.
The ratio remained relatively strong throughout 2021 and 2022, hovering above 4 for most of the periods. This suggests that the company had a comfortable level of liquid assets compared to its short-term obligations during these years.
However, there was a noticeable decrease in the quick ratio from the end of 2022 to the first half of 2024. The ratio dropped to around 2.23 on June 30, 2023, and then increased again to 5.00 by December 31, 2023. This volatility may indicate fluctuations in the company's ability to quickly meet its short-term financial obligations.
Overall, while the quick ratio of TG Therapeutics Inc has shown some variability, it generally stayed above 1 throughout the periods, indicating a solid liquidity position. It would be important to closely monitor the trend to ensure the company continues to maintain a healthy liquidity position in the future.
Peer comparison
Dec 31, 2024